XVIVO
is a Sweden-based medical technology company that develops optimized solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation... Read moreXVIVO
is a Sweden-based medical technology company that develops optimized solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation... Read more
News
Apr 08, 2024
Accesswire
Press Release: XVIVO : Conference call on Interim Report
Apr 04, 2024
BioSpace
XVIVO: XVIVO Perfusion AB Publishes Annual Report 2023
Mar 21, 2024
FinanzNachrichten
XVIVO: Notice to Attend The Annual General Meeting in XVIVO Perfusion AB
Mar 21, 2024
MarketScreener
XVIVO: Xvivo Perfusion : SORP 2024
Feb 29, 2024
FinanzNachrichten
XVIVO: XVIVO Perfusion AB: The First-Ever Transplantation with a Donor Heart Transported Across the Atlantic Ocean - Made Possible by the use of XVIVO's Heart Technology
Feb 01, 2024
Owler
XVIVO Perfusion AB: XVIVO's revenue changed from $53.19M in Sep 2023 to $59.22M in Dec 2023
Jan 25, 2024
BioSpace
XVIVO: XVIVO Presents Report on Operations 2023
Jan 24, 2024
Accesswire
Press Release: XVIVO : Extended Perfusion Time of Livers Can Streamline Planning and Logistics - Enabling More Liver Transplants to be Performed During Daytime
Dec 22, 2023
FinanzNachrichten
XVIVO: XVIVO Perfusion AB: XVIVO Reaches Milestone in Italy: 1,200 Lifesaving Perfusions Performed with Liver Assist
Nov 03, 2023
FinanzNachrichten
XVIVO: XVIVO Perfusion AB: Results from a Australian/New Zealand study using XVIVO's Heart Technology Published
XVIVO Competitors
1
2
3
4
5
6
7
8
9
10